Zacks Investment Research
17 Aug 2026, 16:46 UTC · 5h ago
DD's MemCor MBR System Chosen for Major Plant Upgrade in Australia
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
17 Aug 2026, 16:46 UTC · 5h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
DuPont de Nemours, Inc. (DD) has been selected to provide its MemCor membrane bioreactor system for the expansion of the Lower Molonglo Water Quality Control Center in Australia. — Securing a contract for a major infrastructure project provides incremental revenue and validates technology, though it is likely small relative to overall company scale.
+0.20DuPont's shares have declined 33.4% over the past year, while its industry peers grew by 7.4%. — Significant underperformance relative to the industry indicates systemic internal issues or market skepticism despite individual contract wins.
-0.10Which stocks this story touches
The company secured a significant contract for its membrane bioreactor system in Australia, though shares have underperformed the industry.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
2h ago
